Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Trial
Phase I Safety, Tolerability, Pharmacokinetics And Measurement Of Whole Blood Activity (WBA) Of PNU-100480 After Multiple Oral Doses In Healthy Adult Volunteers
Study Director
Start Date
11 / 2009
Trial Phase
Trial Status
published
Current Enrollment
59
Target Enrollment
59
Overview
Compound Associations
Sutezolid